5-year results for pembrolizumab treatment of advanced melanoma

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Hassel, Jessica C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 22 July 2019
In: The lancet. Oncology
Year: 2019, Jahrgang: 20, Heft: 9, Pages: 1187-1189
ISSN:1474-5488
DOI:10.1016/S1470-2045(19)30483-8
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/S1470-2045(19)30483-8
Verlag: http://www.sciencedirect.com/science/article/pii/S1470204519304838
Volltext
Verfasserangaben:Jessica C. Hassel

MARC

LEADER 00000caa a2200000 c 4500
001 1678477133
003 DE-627
005 20220816235451.0
007 cr uuu---uuuuu
008 191008s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/S1470-2045(19)30483-8  |2 doi 
035 |a (DE-627)1678477133 
035 |a (DE-599)KXP1678477133 
035 |a (OCoLC)1341245001 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hassel, Jessica C.  |d 1975-  |e VerfasserIn  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 aut 
245 1 0 |a 5-year results for pembrolizumab treatment of advanced melanoma  |c Jessica C. Hassel 
246 3 3 |a Five-year results for pembrolizumab treatment of advanced melanoma 
264 1 |c 22 July 2019 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.10.2019 
773 0 8 |i Enthalten in  |t The lancet. Oncology  |d London : The Lancet Publ. Group, 2000  |g 20(2019), 9, Seite 1187-1189  |h Online-Ressource  |w (DE-627)325349770  |w (DE-600)2035574-9  |w (DE-576)100517544  |x 1474-5488  |7 nnas  |a 5-year results for pembrolizumab treatment of advanced melanoma 
773 1 8 |g volume:20  |g year:2019  |g number:9  |g pages:1187-1189  |g extent:3  |a 5-year results for pembrolizumab treatment of advanced melanoma 
856 4 0 |u https://doi.org/10.1016/S1470-2045(19)30483-8  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1470204519304838  |x Verlag 
951 |a AR 
992 |a 20191008 
993 |a Article 
994 |a 2019 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |e 910000PH129790702  |e 911300PH129790702  |k 0/910000/  |k 1/910000/911300/  |p 1  |x j  |y j 
999 |a KXP-PPN1678477133  |e 3520183838 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Hassel","role":"aut","given":"Jessica C.","display":"Hassel, Jessica C."}],"name":{"displayForm":["Jessica C. Hassel"]},"note":["Gesehen am 08.10.2019"],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"The lancet <London> / Oncology"}],"origin":[{"dateIssuedKey":"2000","dateIssuedDisp":"2000-","publisher":"The Lancet Publ. Group","publisherPlace":"London"}],"recId":"325349770","id":{"eki":["325349770"],"issn":["1474-5488"],"zdb":["2035574-9"]},"disp":"5-year results for pembrolizumab treatment of advanced melanomaThe lancet. Oncology","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 22.09.2021"],"pubHistory":["0.2000 -"],"title":[{"title":"The lancet","partname":"Oncology","title_sort":"lancet"}],"part":{"year":"2019","text":"20(2019), 9, Seite 1187-1189","volume":"20","issue":"9","extent":"3","pages":"1187-1189"},"language":["eng"]}],"id":{"doi":["10.1016/S1470-2045(19)30483-8"],"eki":["1678477133"]},"physDesc":[{"extent":"3 S."}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"22 July 2019"}],"recId":"1678477133","titleAlt":[{"title":"Five-year results for pembrolizumab treatment of advanced melanoma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title_sort":"5-year results for pembrolizumab treatment of advanced melanoma","title":"5-year results for pembrolizumab treatment of advanced melanoma"}]} 
SRT |a HASSELJESS5YEARRESUL2220